News Releases

    Rutledge Welcomes Trump Administration’s Opioid Initiative

    March 19, 2018

    Says, ‘I look forward to complementing our efforts in Arkansas with those set out by the President’

    LITTLE ROCK – Arkansas Attorney General Leslie Rutledge welcomes President Donald J. Trump’s bold initiative to combat the nation-wide opioid epidemic, which is decimating Arkansas families and communities. President Trump today announced that the opioid initiative would: reduce demand through education, awareness and prevention of over-prescription; cut off the flow of illicit drugs; and expand treatment opportunities for opioid and other drug addictions.

    “President Trump and his Administration have shown tremendous leadership in battling the opioid crisis and I remain proud to work with leaders across the country on this issue,” said Attorney General Rutledge. “This lethal epidemic knows no bounds and requires an aggressive approach including education, treatment and litigation. Tackling the opioid crisis continues to be a top priority and I look forward to complementing our efforts in Arkansas with those set out by the President.”

    Rutledge has brought a first-in-the-nation curriculum to Arkansas called Prescription for Life. Prescription for Life features a digital platform to help high school students in the State understand the dangers of prescription drug misuse and how to prevent abuse. The program is free to high schools and more information can be found at The curriculum is part of the Attorney General’s already robust prescription drug abuse prevention initiative. The Attorney General’s office also pairs with local law enforcement to offer prescription drug take-backs at each mobile office location, collecting 195 pounds of prescription drugs at mobiles offices across the state in 2017.

    In February, Rutledge appeared alongside U.S. Attorney General Jeff Sessions and state Attorneys General from across the country to speak about the federal government’s plan to tackle the opioid epidemic and the Prescription Interdiction and Litigation Task Force.

    Contact Us
    Sign Up For Attorney General Alerts